SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-016250
Filing Date
2022-11-03
Accepted
2022-11-03 16:16:28
Documents
74
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q knsa-20220930x10q.htm   iXBRL 10-Q 2345268
2 EX-10.1 knsa-20220930xex10d1.htm EX-10.1 987707
3 EX-10.2 knsa-20220930xex10d2.htm EX-10.2 71464
4 EX-10.3 knsa-20220930xex10d3.htm EX-10.3 106509
5 EX-31.1 knsa-20220930xex31d1.htm EX-31.1 11332
6 EX-31.2 knsa-20220930xex31d2.htm EX-31.2 10488
7 EX-32.1 knsa-20220930xex32d1.htm EX-32.1 6299
8 EX-32.2 knsa-20220930xex32d2.htm EX-32.2 6273
9 GRAPHIC knsa-20220930xex10d3001.jpg GRAPHIC 643
10 GRAPHIC knsa-20220930xex10d1001.jpg GRAPHIC 9855
  Complete submission text file 0001558370-22-016250.txt   9358984

Data Files

Seq Description Document Type Size
11 EX-101.SCH knsa-20220930.xsd EX-101.SCH 50536
12 EX-101.CAL knsa-20220930_cal.xml EX-101.CAL 49804
13 EX-101.DEF knsa-20220930_def.xml EX-101.DEF 258014
14 EX-101.LAB knsa-20220930_lab.xml EX-101.LAB 442092
15 EX-101.PRE knsa-20220930_pre.xml EX-101.PRE 360168
68 EXTRACTED XBRL INSTANCE DOCUMENT knsa-20220930x10q_htm.xml XML 1313527
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Filer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38492 | Film No.: 221358250
SIC: 2834 Pharmaceutical Preparations